The 90% minimum effective concentration of ropivacaine for ultrasound-guided interscalene brachial plexus block in children aged 1–10 years: A biased coin design up-and-down sequential allocation trial

Li Yang; Fei Yang; Yaqiong Tian; Ling Liu; Shangyingying Li; Tauseef Ahmad; Yuan Shi; Shengfen Tu

doi:10.1002/pdi3.82

Pediatric Discovery ›› 2024, Vol. 2 ›› Issue (3) : e82 DOI: 10.1002/pdi3.82

RESEARCH ARTICLE

The 90% minimum effective concentration of ropivacaine for ultrasound-guided interscalene brachial plexus block in children aged 1–10 years: A biased coin design up-and-down sequential allocation trial

Author information +

History +

PDF

Abstract

Ropivacaine is a commonly used local anesthetic for brachial plexus blocks in children, but the minimum effective dose of ropivacaine for interscalene brachial plexus blocks has not been reported. The aim of this study was to determine the 90% minimum effective concentration (MEC90) of ropivacaine for an ultrasound-guided interscalene brachial plexus block (ISB). A total of 155 patients, aged from 1 to 10 years, underwent unilateral surgical procedures on areas of the upper extremity not innervated by the ulnar nerve. The biased coin design up-and-down sequential method (BCD-UMD) was used to determine the MEC90 of ropivacaine for ultrasound-guided ISB. In our study, the initial concentration of ropivacaine was 0.07% in the toddler group and 0.09% in the preschool and school-age groups. During the trial, the concentration of ropivacaine for each subsequent patient was determined by the blocking effect of the previous patient. In case of failure, the concentration for the next patient was increased by 0.01%. Otherwise, the concentration was either decreased by 0.01%, with a probability of 0.11, or kept the same, with a probability of 0.89. Overall, the MEC90 of ropivacaine was 0.104% (95% confidence interval (CI), 0.070%–0.106%) in the toddler group, 0.114% (95% CI, 0.090%–0.117%) in the preschool group, and 0.133% (95% CI, 0.099%–0.136%) in the school-age group. No adverse events occurred. Our study showed that lower concentrations of ropivacaine could provide effective nerve blocks and reduce the risk of local anesthetics.

Keywords

interscalene brachial plexus block / MEC90 (90% minimum effective concentration) / pediatrics / ropivacaine / ultrasound-guided

Cite this article

Download citation ▾

Li Yang, Fei Yang, Yaqiong Tian, Ling Liu, Shangyingying Li, Tauseef Ahmad, Yuan Shi, Shengfen Tu. The 90% minimum effective concentration of ropivacaine for ultrasound-guided interscalene brachial plexus block in children aged 1–10 years: A biased coin design up-and-down sequential allocation trial. Pediatric Discovery, 2024, 2(3): e82 DOI:10.1002/pdi3.82

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	MarhoferP, Sitzwohl C, GreherM, KapralS. Ultrasound guidance for infraclavicular brachial plexus anaesthesia in children. Anaesthesia. 2004;59(7):642-646.

[2]	de Jose MariaB, Tielens LK. Vertical infraclavicular brachial plexus block in children: a preliminary study. Paediatr Anaesth. 2004;14(11):931-935.

[3]	FleischmannE, Marhofer P, GreherM, WaltlB, Sitzwohl C, KapralS. Brachial plexus anaesthesia in children: lateral infraclavicular vs axillary approach. Paediatr Anaesth. 2003;13(2):103-108.

[4]	McClellanKJ, FauldsD. Ropivacaine: an update of its use in regional anaesthesia. Drugs. 2000;60(5):1065-1093.

[5]	LiT, YeQ.-G, WuD.-Z, Li J, YuJ.-G. Dose-response studies of Ropivacaine in blood flow of upper extremity after supraclavicular block: a double-blind randomized controlled study. BMC Anesthesiol. 2017;17(1):161.

[6]	DixonWJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991;15(1):47-50.

[7]	InceI, AksoyM, DostbilA, Tuncer K. Can we use lower volume of local anesthetic for infraclavicular brachial plexus nerve block under ultrasound guidance in children? J Clin Anesth. 2017;41:132-136.

[8]	DurhamSD, Flournoy N, RosenbergerWF. A random walk rule for phase I clinical trials. Biometrics. 1997;53(2):745-760.

[9]	TranDQH, DuganiS, CorreaJA, Dyachenko A, AlsenosyN, FinlaysonRJ. Minimum effective volume of lidocaine for ultrasound-guided supraclavicular block. Reg Anesth Pain Med. 2011;36(5):466-469.

[10]	WangW.-P, ChenH, LiS, et al. Median effective dose of 0.2% ropivacaine for ultrasound-guided Median nerve block in young children. Anaesth Crit Care Pain Med. 2023;42(1):101159.

[11]	IngelmoP, Frawley G, AstutoM, et al. Relative analgesic potencies of levobupivacaine and ropivacaine for caudal anesthesia in children. Anesth Analg. 2009;108(3):805-813.

[12]	SaranteasT, Finlayson RJ, TranDQH. Dose-finding methodology for peripheral nerve blocks. Reg Anesth Pain Med. 2014;39(6):550-555.

[13]	StylianouM, Proschan M, FlournoyN. Estimating the probability of toxicity at the target dose following an up-and-down design. Stat Med. 2003;22(4):535-543.

[14]	ZadrazilM, Opfermann P, MarhoferP, WesterlundAI, HaiderT. Brachial plexus block with ultrasound guidance for upper-limb trauma surgery in children: a retrospective cohort study of 565 cases. Br J Anaesth. 2020;125(1):104-109.

[15]	DruzhininD, Naumova E, NikitinS. Nerve ultrasound normal values in children and young adults. Muscle Nerve. 2019;60(6):757-761.

[16]	FangG, WanL, MeiW, YuHH, LuoAL. The minimum effective concentration (MEC90) of ropivacaine for ultrasound-guided supraclavicular brachial plexus block. Anaesthesia. 2016;71(6):700-705.

[17]	GreletT, BeschG, PuyraveauM, et al. Minimum effective concentration of ropivacaine for 90% ultrasound-guided axillary brachial plexus block, with or without intravenous dexamethasone. J Clin Anesth. 2021;75:110468.